GRETCHEN ADAMS: Open Payments
NPI 1689026692 · POMONA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,157 in 51 payments from 11 companies in 2025. Trend: 2023 $1,783 · 2024 $1,321 · 2025 $1,157
Food & beverage: $1,157
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 12 | $273 |
| Indivior Inc. | 8 | $213 |
| E.R. Squibb & Sons, L.L.C. | 10 | $155 |
| Janssen Pharmaceuticals, Inc | 5 | $123 |
| Neurocrine BioSciences, Inc. | 4 | $97 |
| Braeburn Inc. | 4 | $86 |
| ABBVIE INC. | 2 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Luye Pharma (USA) Ltd. | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 1 | $36 |
Products named: SUBLOCADE, ARISTADA, COBENFY, INVEGA SUSTENNA, INGREZZA, BRIXADI, VIVITROL, MAVYRET.
Industry payments across CA — which companies pay providers there.
